Neoadjuvant Immunotherapy in TNBC and Targeted LND in Breast Cancer: 2023 Best of Breast Conference Total Health | Oncology 1:17 1 year ago 305 Далее Скачать
Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer VJOncology 1:00 1 year ago 190 Далее Скачать
KEYNOTE 522: pembrolizumab as neoadjuvant treatment for early TNBC VJOncology 4:20 5 years ago 798 Далее Скачать
Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS ecancer 3:34 3 months ago 52 Далее Скачать
KEYNOTE-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer VJOncology 4:20 1 year ago 3 461 Далее Скачать
Neoadjuvant and adjuvant therapy in triple negative breast cancer ecancer 2:52 6 years ago 602 Далее Скачать
Key clinical trials investigating immunotherapy in HER2+ and HR+ breast cancer VJOncology 6:54 3 years ago 815 Далее Скачать
Emerging immunotherapy beyond checkpoint inhibitors for TNBC VJOncology 1:30 2 years ago 235 Далее Скачать
The predictive value of treatment response after neoadjuvant therapy VJOncology 1:29 2 years ago 498 Далее Скачать
KEYNOTE-522 updates: Pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast... ecancer 4:54 5 years ago 688 Далее Скачать
Effectiveness of ICIs in the neoadjuvant and post-neoadjuvant breast cancer setting VJOncology 1:59 2 years ago 59 Далее Скачать
Neo-adjuvant therapy for different cancers in the Philippines ecancer 5:07 1 year ago 321 Далее Скачать
Adjuvant/neoadjuvant therapy trials for breast cancer at SABCS 2021 VJOncology 2:31 3 years ago 390 Далее Скачать
